$MRVL

Koopmans Chris sold $2.1M of MRVL (indirect holdings)

Koopmans Chris (President and COO) sold 10,000 indirectly-held shares of Marvell Technology, Inc. (MRVL) at $205.87 ($2.06M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Koopmans Chris
Published Jun 2, 2026, 12:32 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 2, 2026, 1:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MRVL
Neutral
medium confidence
Mentioned
$MRVL
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRVLNeutralLow
01

Why it matters

The main trading relevance is potential short-term sentiment impact from insider selling; however, 10b5-1 plans are designed to reduce timing-based information content.

02

Market read

A routine 10b5-1 insider sale; any effect is likely limited to near-term sentiment rather than fundamentals.

03

What to watch

The filing does not indicate why the sale occurred (taxes/diversification are common), and it provides no new operational or financial information about Marvell.

Relevance 7/10Novelty 3/10Timing: SEC Form 4 filed/posted after-hours on 2026-06-01 (for June 1 sale).

Background

This is an SEC Form 4 insider transaction disclosure: Koopmans (President and COO) sold 10,000 MRVL shares at ~$205.87 on 2026-06-01, with an indirect ownership form and a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$MRVLNeutralMedium confidence
Context

Marvell’s President/COO Chris Koopmans sold $2.06M of MRVL shares via an open-market transaction under a 10b5-1 plan on June 1.

Expected impact

Limited, mostly sentiment-driven; any impact should fade unless accompanied by other negative company news.

Evidence & confidence

The filing is a routine insider transaction with a pre-arranged 10b5-1 plan, reducing the likelihood of new negative information.

Market effects

No direct sector read-through; this is company-specific insider activity.

None.

None.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, the market may overreact; price action could be muted or even stabilize quickly.

Key entities

  • Marvell Technology, Inc.

    Subject of the insider transaction disclosure; officer sale under 10b5-1.

  • Chris Koopmans

    President and COO who sold MRVL shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MRVLMed

Should You Sell Your Marvell Stock Now That Higher Forecasts Are Not Enough?

Marvell Technology (MRVL) raised its revenue outlook to $18B for fiscal 2028, but its stock fell 16.4% over three months. The company trades at a P/E of 88.0, significantly higher than the S&P 500's 22.5. Management expects revenue growth of about 50% in fiscal 2028, with major gains from an AI chip deal anticipated in fiscal 2029 and beyond.

$MRVLMed

Marvell Technology (MRVL) Shares Skyrocket, What You Need To Know

Marvell Technology (MRVL) shares rose 6.1% after announcing 2nm optical interconnect demonstrations for AI data centers. Morgan Stanley raised its price target to $268. Shares closed at $257.14, up 5.5%. The company is up 187% YTD but 19% below its 52-week high. Positive macroeconomic factors and sector-wide AI chipmaker rally contributed to the surge.

$MRVLMed

Why Marvell Stock Rallied Today

Marvell Technology (MRVL) shares rose 6% on Monday after announcing a 2nm optical interconnect demo for AI data centers. Morgan Stanley raised its price target to $268, citing potential $40B+ fiscal 2030 revenue. MRVL grew revenue 42% to $8.2B in fiscal 2026, forecasting 45% and 50% growth for fiscal 2027 and 2028, respectively.